Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CRWD vs GSK✓SelectedUSD · GSKCRWD vs GSK performance historyLatest closeAs of-1.63%11/17
Stock and ETF performance explorer

CRWD vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+65.8%
GSK return
+7.1%
Excess return
+58.7%
Maximum drawdown
-33.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.6%-2.3%+0.7%-2.4%
7D-2.7%-3.0%+0.3%-3.7%
30D-3.4%+0.4%-3.8%-3.1%
3M+2.7%-1.2%+3.8%+2.4%
6M+47.8%+0.9%+46.9%+49.4%
YTD+87.4%+4.0%+83.4%+79.4%
1Y+65.8%+7.3%+58.5%+58.6%
All+65.8%+7.1%+58.7%+58.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling